We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$677M
AUM Growth
-$50M
(-6.9%)
Cap. Flow
-$67.1M
Cap. Flow
% of AUM
-9.92%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.2M |
| 2 |
Kimberly-Clark
KMB
|
+$8.57M |
| 3 |
SBA Communications
SBAC
|
+$7.81M |
| 4 |
PG&E
PCG
|
+$5.73M |
| 5 |
Advance Auto Parts
AAP
|
+$5.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.6M |
| 2 |
Pfizer
PFE
|
+$14.6M |
| 3 |
Dominion Energy
D
|
+$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.25% |
| 2 | Technology | 16.12% |
| 3 | Industrials | 11.55% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
476
DELISTED
CATALENT, INC.
CTLT
| $316K | 0.05% |
+7,299
| New | +$321K |
|
|
BBBY
477
Bed Bath & Beyond
BBBY
$424M
| $316K | 0.05% |
+10,672
| New | +$197K |
|
478
Ralph Lauren
RL
$24.2B
| $316K | 0.05% |
+2,559
| New | +$295K |
|
479
BellRing Brands
BRBR
$1.32B
| $315K | 0.05% |
+8,596
| New | +$308K |
|
480
Medtronic
MDT
$114B
| $313K | 0.05% |
3,557
-41,377
| -92% | -$3.56M |
|
481
Abbott
ABT
$187B
| $312K | 0.05% |
2,866
-75,329
| -96% | -$8.03M |
|
482
Extreme Networks
EXTR
$3.16B
| $312K | 0.05% |
+11,987
| New | +$236K |
|
|
RDFN
483
DELISTED
Redfin
RDFN
| $312K | 0.05% |
+25,135
| New | +$245K |
|
|
ORC
484
Orchid Island Capital
ORC
$1.29B
| $312K | 0.05% |
30,160
+2,039
| +7% | +$21.1K |
|
485
Robinhood
HOOD
$85B
| $312K | 0.05% |
+31,242
| New | +$291K |
|
486
AtriCure
ATRC
$2.12B
| $311K | 0.05% |
6,300
-7,345
| -54% | -$339K |
|
487
Harmony Biosciences
HRMY
$2.28B
| $309K | 0.05% |
+8,788
| New | +$303K |
|
488
Huazhu Hotels Group
HTHT
$13.2B
| $307K | 0.05% |
7,914
-4,485
| -36% | -$195K |
|
489
Morningstar
MORN
$7.53B
| $304K | 0.04% |
1,551
+493
| +47% | +$97.6K |
|
490
EOG Resources
EOG
$74.6B
| $303K | 0.04% |
2,651
-7,953
| -75% | -$908K |
|
491
Ryanair
RYAAY
$30.9B
| $303K | 0.04% |
+6,845
| New | +$276K |
|
|
GOOS
492
Canada Goose Holdings
GOOS
$849M
| $302K | 0.04% |
16,968
-29,701
| -64% | -$534K |
|
493
EXL Service
EXLS
$5.3B
| $302K | 0.04% |
+9,990
| New | +$315K |
|
494
Genuine Parts
GPC
$18.4B
| $300K | 0.04% |
1,774
-21,151
| -92% | -$3.46M |
|
495
Celanese
CE
$4.86B
| $300K | 0.04% |
+2,590
| New | +$281K |
|
496
Salesforce
CRM
$162B
| $299K | 0.04% |
+1,416
| New | +$289K |
|
|
LAND
497
Gladstone Land Corp
LAND
$351M
| $297K | 0.04% |
18,236
+7,829
| +75% | +$127K |
|
498
Medpace
MEDP
$16.8B
| $297K | 0.04% |
1,235
-671
| -35% | -$139K |
|
499
NetEase
NTES
$85B
| $295K | 0.04% |
3,047
-8,822
| -74% | -$797K |
|
500
Skywest
SKYW
$4.18B
| $294K | 0.04% |
+7,217
| New | +$214K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.
- Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
- Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
- Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
- Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
- Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
- Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
- Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.
Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.